First Time Loading...

Selecta Biosciences Inc
NASDAQ:SELB

Watchlist Manager
Selecta Biosciences Inc Logo
Selecta Biosciences Inc
NASDAQ:SELB
Watchlist
Price: 0.7465 USD 5.14% Market Closed
Updated: May 1, 2024

Wall Street
Price Targets

SELB Price Targets Summary
Selecta Biosciences Inc

There are no price targets for SELB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Selecta Biosciences Inc Competitors:
Price Targets
096530
Seegene Inc
70% Upside
DSGN
Design Therapeutics Inc
38% Upside
IOVA
Iovance Biotherapeutics Inc
123% Upside
CDNA
CareDx Inc
48% Upside
TWST
Twist Bioscience Corp
33% Upside
688319
Chengdu Olymvax Biopharmaceuticals Inc
169% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
51% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
71% Upside

Revenue
Forecast

Revenue Estimate
Selecta Biosciences Inc

For the last 7 years the compound annual growth rate for Selecta Biosciences Inc's revenue is 52%. The projected CAGR for the next 2 years is -39%.

52%
Past Growth
-39%
Estimated Growth
Estimates Accuracy
19%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Selecta Biosciences Inc

Operating Income forecast
is not available for
Selecta Biosciences Inc

Net Income
Forecast

Net Income Estimate
Selecta Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SELB's stock price target?
Not Available

SELB doesn't have any price targets made by Wall Street professionals.

What is Selecta Biosciences Inc's Revenue forecast?
Projected CAGR
-39%

For the last 7 years the compound annual growth rate for Selecta Biosciences Inc's revenue is 52%. The projected CAGR for the next 2 years is -39%.